Atul Butte, MD, PhD
KEYNOTE
Precisely Practicing Medicine from 700 Trillion Points of Data
Tuesday, April 4 | 8:30am—9:30am
There is an urgent need to take what we have learned in our new data-driven era of medicine and use it to create a new system of precision medicine that delivers the best, safest, most cost-effective preventative or therapeutic intervention at the right time, for the right patients. Dr. Atul Butte will discuss the groundbreaking work of the UC Health System in integrating electronic health records data and translating analytics into new evidence for drug efficacy, new savings from better medication choices, and new insights into the transformative power of precision medicine.
Biography: Atul Butte, MD, PhD, is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and inaugural Director of the Bakar Computational Health Sciences Center at the University of California, San Francisco. He is also the Chief Data Scientist for the University of California Health System. Dr. Butte leads a team focused on integrating electronic health records data from more than 8 million patients across the UC Health System and using this data to drive diagnostics, therapeutics, and a deeper understanding of disease. Dr. Butte earned his MD at Brown University, and then trained in pediatrics and pediatric endocrinology at Children's Hospital Boston. He also holds a BA in computer science from Brown, and a PhD in health sciences and technology from Harvard Medical School and MIT.
Tuesday, April 4
REMS Strategies: Successful Management
Tuesday, April 4
9:30am—10:15am
Risk mitigation through the successful application of REMS requirements is crucial to ensuring safe and effective use of medications as well as gaining access to REMS medications. In many cases, ensuring program compliance with REMS requirements requires careful logistical planning for a specialty pharmacy including education, operational (workflow, shipping) impacts, and reporting requirements. In this presentation, health systems share challenges, the lessons learned, and benefits after implementing different REMS programs
Learning Objectives:
- Describe the FDA REMS program and how it impacts the dispensing of specialty medications that have REMS requirements.
- Discuss the various operational processes involved in implementing procedures within a health system specialty pharmacy to meet REMS requirements for specialty medications
- Describe solutions to various challenges in dispensing REMS specialty medications including documentation of patients’ testing requirements, establishing systems for patient monitoring, and reporting of required data to the manufacturer and FDA.
- Moderator: Burnis Breland, MS, PharmD, FASHP, Regional Account Director , Acentrus Specialty
- Lisa Cristofaro, BS Pharm, BCACP, Market Access Manager, University of Rochester
- Jason Bailly, PharmD, CSP, Specialty Pharmacist in Charge, UC San Diego Health
Payor Partnerships: Where Outcomes, Value, and Data Meet
Tuesday, April 4
10:30am—11:15am
Health system specialty pharmacies are using innovative strategies to build partnerships with PBMs and other payor networks. Learn from health systems that are removing access barriers by demonstrating clinical value and optimized financial outcomes.
Learning Objectives
- Describe different strategies and tactics health system specialty pharmacies can leverage to demonstrate clinical value to payor networks
- Define value-based care pharmacy metrics contained within risk-sharing payor contracts
- Express pharmacy’s impact on clinical outcomes, revenue streams, and administrative value to payor networks
- Outline different pharmacy-led interventions that improve health outcomes, expand access, and/or decrease cost of care
- Joshua Weber, Pharm.D, MBA-HCM, BCMTMS, Director, Specialty Pharmacy Services, UVA Health
ASHP Specialty Pharmacy Results: A Sneak Peek
Tuesday, April 4
1:30pm—2:00pm
ASHP conducts focused national surveys on integrated advanced practice specialty pharmacy models in hospitals and health systems. This session will provide insights into the most recent outcomes of ASHP’s surveys including Training and Credentials, Operations, Payer Access, Business Relationships and Financial Management, and Patient Care Services, Clinical Care, and Documentation.
Learning Objectives
- Explain information related to the ASHP National Surveys on health system specialty pharmacy practice
- Describe hospital and health system specialty pharmacy organizational structures
- Discuss ASHP opportunities to support national initiatives to advance health system specialty pharmacy
- David Chen, RPH, MBA, Assistant Vice President for Pharmacy Leadership and Planning, Pharmacy Practice Sections, ASHP
Infusion Integration: Site of Care Trends, Challenges, and Opportunities
Tuesday, April 4
2:00pm—2:45pm
How do health systems operationalize infusion care between specialty pharmacies, infusion clinics, and home infusion? Learn market trends and hear from health systems that have retained infusion services within their systems to maximize care integration, better serve patients, lower costs, improve margins and increase revenue.
Learning Objectives
- Describe current specialty infusion trends and characteristics of different sites of care.
- Discuss current practices in health systems to operationalize prescription routing and integrate specialty and home infusion.
- Identify challenges and barriers in specialty infusion.
- List strategies to improve capture of revenue and improve margins for specialty infusions.
- Steve Kennedy, PharmD, CSP, Senior Consulting Solutions Director, Vizient
- Scott Copple, RPh, Pharmacy Manager, Mercy Specialty and Home Infusion Pharmacy Riverport
- William Kupka, PharmD, BCPS, 340B ACE, Pharmacy Director, University Hospitals
Data Driven Decision Making: A Specialty Pharmacy Framework
Tuesday, April 4
3:00pm—3:45pm
Every health system faces daily decisions about how to allocate limited resources. Learn from a team that has developed a decision-making framework based on operational and performance metrics — and applied this framework in several clinics to evaluate growth opportunities, foster innovation, streamline strategic focus, and standardize the way decisions are made
Learning Objectives
Session participants will be able to:
- Describe various sources of operational metrics
- Interpret opportunity, capacity, and performance calculations
- Evaluate opportunity using capacity and performance metrics
- Karen Thomas, PharmD, PhD, MBA, Outcomes Coordinator, University of Illinois at Chicago - UI Health
Specialty Pharmacy Shipping: Overcoming Challenges
Tuesday, April 4
3:45pm—4:30pm
Specialty Pharmacy shipping – it’s necessary to get product to patients, it’s costly, it’s ripe with opportunities for process breakdowns and certain standards must be met to maintain specialty pharmacy accreditation, medication viability, as well as patient safety and satisfaction. Specialty pharmacies must implement workflow changes, consider vendor partnerships, and leverage network best practices to mitigate shipping issues while minimizing cost, improving patient safety and satisfaction, and decreasing medication waste. Gain best practices you can implement in your specialty pharmacy as our speakers share their approaches and industry expertise to overcoming shipping challenges, including the associated economic and patient impact.
Learning Objectives
- Identify points in the shipping process where errors or process breakdowns occur with the most frequency
- Determine the potential workflow changes that will have the greatest positive impact on overcoming your shipping challenges
- Considering partnering with a technology vendor to reduce staff burden and expense while improving delivery metrics and patient satisfaction
- Leverage shared best practices to apply within your specialty pharmacy
- Moderator: Allison Bystriansky, MBA, Regional Account Director , Acentrus Specialty
- Marc Choquette, PharmD, MBA, Pharmacy Operations Manager, Saint Luke's Advanced Care Pharmacy
- William Gatlin, PharmD, Chief Clinical Officer, ParcelShield
- Sarah Thornton, PharmD, BCACP, Specialty Pharmacy Compliance Officer, University of Arkansas for Medical Sciences
Wednesday, April 5
Acentrus Specialty – Today and Tomorrow
Wednesday, April 5
8:30am—9:00am
Since its founding, Acentrus has been a leader in defining specialty pharmacy best practices — and working with manufacturers and payors to demonstrate that these best practices deliver better outcomes for patients at greater cost savings for all stakeholders. Julia Hancock, Vice President and General Manager, will share an update on the network’s strategic focus.
- Julia Hancock, MBA, Vice President and General Manager, Acentrus Specialty
The Manufacturers' Perspective on Data Collaboration: Why It Matters
Wednesday, April 5
9:00am—9:45am
How can drug manufacturers help health system specialty pharmacies strengthen patient care? This presentation will look at the value of health system specialty pharmacy data from a manufacturers perspective — and how network administrators such as Acentrus are uncovering new insights into drug therapies through benchmarking with the power to optimize medication performance and patient health outcomes.
Learning Objectives
- Show how Seagen and BeiGene partner with a network administrator (i.e. Acentrus) to deliver patient metrics for clients by utilizing a hybrid LDD model
- Describe how a manufacturer partners with a network administrator to generate patient metrics and performance benchmarking utilizing a hybrid LDD model
- Recognize the challenges at the manufacturer level to show congruency between various sources of data
- Identify opportunities for collaboration within the Acentrus client portfolio to continue to demonstrate the high value of the Health System Specialty Pharmacy
- Construct opportunities to collaborate with a network administrator to demonstrate the high value of the Health System Specialty Pharmacy
- Moderator: Michelle Lee, PharmD, RPh, Portfolio Executive, Acentrus Specialty
- Jillian Dura, PharmD, BCOP, Assistant Director, Specialty Accounts, Seagen
- Torry Thomas RN, BSN, Director, National Accounts IDN/HS, BeiGene USA, Inc.
Combating Health Inequities: Addressing Social Determinants of Health
Wednesday, April 5
10:15am—11:00am
Specialty pharmacies are uniquely positioned to identify social determinants of health that impact medication adherence and health outcomes. Care coordination is vital to ensuring patients have the assistance and advocacy they need throughout their treatment journeys. Pharmacists are well positioned to identify and address social determinants of health barriers, and specialty pharmacy teams do so through innovative, patient-focused approaches to care. In this presentation, we will describe strategies to improve health equity and patient outcomes.
Learning Objectives
- Describe social determinants of health and how they impact the quality and safety of medication use
- Identify practical, real-world solutions to improve health disparities and deliver more equitable care by improving access, adherence, and outcomes
- Propose future opportunities for specialty pharmacies to partner with stakeholders (payers and manufacturers) to overcome these inequities
- Moderator: Neesha Thakkar, PharmD, BCPS, Regional Account Director , Acentrus Specialty
- Kama Thomas, Pharm D, Health Outcomes and Research Coordinator, Froedtert Health
- Heather Dalton, PharmD, MS, Specialty Pharmacy Manager, Froedtert Health
- Mackenzie Clark, PharmD, APh, BCPS, BCGP, Clinical Supervisor, University of California, San Francisco Health
Leveraging Data: Demonstrate Pharmacy Value Beyond Dispensing
Wednesday, April 5
11:00am—11:45am
While specialty pharmacy teams are well aware of the critical role pharmacist interventions play in health outcomes, documenting this can be difficult. In this session, we’ll review a methodology that allows pharmacies to generate reportable documentation in EHRs. We’ll also look at strategies to communicate and leverage this data to demonstrate how integrated care teams are driving better outcomes.
Learning Objectives
- Discuss strategies to proactively identify outcomes and data needs
- Review an approach to integrate discrete data collection into practice
- Examine opportunities for automated reporting and dashboards
- Summarize ways to leverage documentation, data, and reporting for multiple business purposes
- Jennifer Loucks, PharmD, BCPS, Ambulatory Clinical Pharmacy Manager, The University of Kansas Health System
- Sarah K. Daniel, PharmD, MS, BCPS, Assistant Director of Pharmacy, The University of Kansas Health System
- Samaneh Wilkinson, MS, PharmD, CPEL, Senior Director of Ambulatory Pharmacy Services, The University of Kansas Health System
A Time for Change: Biosimilars
Wednesday, April 5
1:00pm—1:45pm
Biosimilars are on the rise in the U.S. with a wave of growth anticipated this year. A great deal of attention has been focused on the many Humira biosimilars entering the market in 2023. This presentation will look at market trends and utilization as well as how health systems and payers are managing formulary decision-making and costs as biosimilars boom.
Learning Objectives
- Describe the factors affecting utilization and uptake of adalimumab biosimilar products
- Assess market shifts and trends in the autoimmune anti-inflammatory landscape in 2023
- Discuss the impact of payer influence on the utilization of biosimilars.
- Explain the correlation of genetic testing to biosimilar selection and utilization
- Shannon Holden, PharmD, BCACP, Sr Clinical Manager, Pharmacy, Vizient Inc
- Dean Erhardt, BBA, MBA, President & CEO, D2 Solutions
Exploring Practice Models: Clinical and Specialty Pharmacy
Wednesday, April 5
1:45pm—2:30pm
Clinical and specialty pharmacy practice models vary across health system specialty pharmacies. Different practice models will be presented from 2-3 organizations that will provide tangible information/workflows that can be adopted by newer specialty pharmacies or provide ideas for expansion for more established specialty pharmacies.
Learning Objectives
- Describe various practice models for clinical pharmacists and their roles in specialty pharmacy.
- Apply the knowledge of different practice models to your own practice for implementation and/or adjustment.
- Describe the importance of an integrated clinical pharmacist.
- Lanh Dang, PharmD, BCACP, Clinical Ambulatory Care Pharmacist—Multispecialty, UF Health Jacksonville
- Alana Rice, PharmD, Pharmacy Clinical Practice Specialist - GI/Hepatology, University of Texas Medical Branch
- Mike James, PharmD, MBA, Associate ,Chief Pharmacy Officer, UAB Hospital
340B Update: Meeting Specialty Pharmacy Challenges and Moving Forward
Wednesday, April 5
2:45pm—3:45pm
The 340B Drug Pricing Program celebrated its 30th anniversary this past November. We’ll highlight major events and influences in the program’s history and how covered entities, manufacturers, government agencies, and others have shaped 340B into what we know today. The session will discuss access to specialty medications at 340B prices and ways to work with 340B stakeholders to strengthen medication access for the safety-net hospitals providing care to underserved communities.
Learning Objectives
- Describe how the 340B program has become a vital program and key driver for growth of health system specialty pharmacies.
- Discuss the challenges of covered entity specialty pharmacies gaining access to restricted distribution specialty medications, including the impact of the GPO and orphan drug rules.
- Discuss implications of recent 340B events including restrictions on use of contract pharmacies, vertical payer and PBM alignment and network restrictions impacting reimbursement, and calls for 340B program revisions and transparency. challenges to patient definition.
- Moderator: Burnis Breland, MS, PharmD, FASHP, Regional Account Director , Acentrus Specialty
- James Jorgenson, RPh, MS, FASHP, Chief Executive Officer and Board Chair, Visante Consulting
- Chris Hatwig, MS, RPh, FASHP, President, Apexus
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Apexus. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Platinum Sponsor
Gold Sponsors
Bronze Sponsors
Strategic Partner
Connect With Us
